Interesse Geral
Relatório | Pessoas plenamente vacinadas respondem por 1,2% das mortes por Covid-19 na Inglaterra.
14 Set, 2021 | 14:29hFully vaccinated people account for 1.2% of England’s Covid-19 deaths – The Guardian
Relatório original: Deaths involving COVID-19 by vaccination status, England: deaths occurring between 2 January and 2 July 2021 – Office for National Statistics
Covid: experts do Reino Unido recomendam vacina com única dose para crianças de 12 a 15 anos de idade.
14 Set, 2021 | 14:28hCovid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors – BBC
Ver também: Covid-19: Children aged 12-15 should be offered vaccine, say UK’s chief medical officers – The BMJ
Opinião | Não transforme pesquisadores em início de carreira em “ghost authors” (autores ocultos). Dê a nós o nosso devido crédito.
14 Set, 2021 | 14:16hDon’t make early career researchers ‘ghost authors.’ Give us the credit we deserve – Science
Quatro fatores que aumentam o risco de pessoas vacinadas contraírem COVID.
12 Set, 2021 | 22:20hFour factors that increase the risk of vaccinated people getting COVID – The Conversation
Perspectiva | Estamos pedindo o impossível às vacinas – “Há muito tempo, a proteção completa contra infecções tem sido aclamada como o “Santo Graal” da vacinação. Pode ser que isso seja simplesmente inalcançável.”
12 Set, 2021 | 22:19hWe’re Asking the Impossible of Vaccines – The Atlantic
Comentário no Twitter
A really great read from @KatherineJWu on why it may be too much to expect vaccines—#covid19 or otherwise—to prevent infection. Still the vaccines are great at what we need—preventing hospitalizations and deaths! https://t.co/ufVBVn4wd1
— Jennifer Nuzzo, DrPH (@JenniferNuzzo) September 11, 2021
Estudo randomizado | Limitação do tempo de tela para jovens adultos após concussão resulta em duração mais curta dos sintomas.
12 Set, 2021 | 22:03hComunicado de imprensa: Limiting screen time for young adults after concussion results in shorter duration of symptoms – University of Massachusetts Medical School
Estudo original: Effect of Screen Time on Recovery From Concussion: A Randomized Clinical Trial – JAMA Pediatrics (link para o resumo – $ para o texto completo)
Comentário no Twitter
The use of electronic screen time in the first 48 hours after sustaining a concussion is associated with a longer time to recovery, a single-center randomized-clinical trial reports https://t.co/PFAj5OoqNc
— JAMA Pediatrics (@JAMAPediatrics) September 7, 2021
Máscaras contra COVID passam em seu maior teste – “Um estudo rigoroso mostra que máscaras cirúrgicas são altamente protetoras, mas máscaras de tecido, nem tanto.”
12 Set, 2021 | 21:54hFace masks for COVID pass their largest test yet – Nature
Estudo original: [Preprint] Largest study of masks yet details their importance in fighting Covid-19.
Comentário no Twitter
Face masks for COVID pass their largest test yet – I & others comment. It is true that I bought pink surgical masks (my favorite color) in response to this study for when I am around unvaccinated adults (or indoor public spaces for now)https://t.co/nFhlcqwrjv
— Monica Gandhi MD, MPH (@MonicaGandhi9) September 9, 2021
Diretriz | Cannabis medicinal ou canabinoides para dor crônica.
12 Set, 2021 | 21:45hMedical cannabis or cannabinoids for chronic pain: a clinical practice guideline – The BMJ
Editorial: Medical cannabis for chronic pain – The BMJ
Conteúdos relacionados: Cannabis and Cannabinoid Analgesia position statement – “Due to the lack of high-quality clinical evidence, the IASP does not currently endorse general use of cannabis and cannabinoids for pain relief.” (várias fontes sobre o tema)
Comentário no Twitter
A panel of international experts make a weak recommendation for a trial of non-inhaled medical cannabis or cannabinoids for people living with chronic pain, if standard care is not sufficient
Guideline includes a visual summary #BMJInfographic @will_s_t https://t.co/25ML4DZcvz pic.twitter.com/mjbDOyYVLL
— The BMJ (@bmj_latest) September 9, 2021
OMS faz apelo para que países adiem as doses de reforços contra COVID-19 até 2022 para priorizar a vacinação das populações sob maior risco ao redor do mundo e que ainda não receberam nem a primeira dose de vacina.
12 Set, 2021 | 20:58hVer também:
WHO chief urges halt to booster shots for rest of the year – Associated Press
WHO extends moratorium on booster COVID vaccine doses – CIDRAP
AstraZeneca encabeça o alerta contra a corrida por doses de reforço – “Dar a terceira dose aos mais vulneráveis, que talvez não tenham feito uma resposta imunológica completa com as duas primeiras doses, é ‘sensato’, mas qualquer decisão sobre dar a terceira dose ‘para grande parcela da população’ e ampliar a proteção obtida pelas duas primeiras doses deve ser baseada em dados clínicos.”
12 Set, 2021 | 20:57hAstraZeneca bosses warn against rush for boosters – BBC
Comentário no Twitter (fio – clique para saber mais)
"Moving too quickly to boost across the entire adult population will deprive us of these insights, leaving this important decision to rest on limited data," Mr Soriot and Sir Mene write.https://t.co/xTAk7yyu5G
— The Sharing Scientist (@ScienceShared) September 8, 2021